Using nanomaterials to address SARS-CoV-2 variants through development of vaccines and therapeutics

Using nanomaterials to address SARS-CoV-2 variants through development of vaccines and therapeutics

Nanomaterials have played a significant role in effectively combating the global SARS-CoV-2 pandemic that began in December 2019 through the development of vaccines as well as antiviral therapies. These versatile, tunable materials can interact and deliver a broad range of biologically relevant mole...

Full description

Bibliographic Details
Main Authors: Maria Victoria Hangad, Sarah Keshvani, Niya Kelpin, Jonathan Walters-Shumka, McKayla Hood, Cameo Volk, Danika Pal, Stephanie M. Willerth
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Materials
Subjects:
nanotechnology
COVID-19
nanomaterials
vaccine development
antiviral therapeutics
disease-modelling
Online Access:https://www.frontiersin.org/articles/10.3389/fmats.2022.1039247/full

Internet

https://www.frontiersin.org/articles/10.3389/fmats.2022.1039247/full

Similar Items